转棒实验是运动协调方面药物筛选的重要方法。根据 N.W Dunham 和 T.S Miya 1957年的论文。在1960年，Ugo Basile设计了第一个RotaRod转棒仪。

数据读取：	液晶显示	数据采集：	52050-07软件
转棒开始：	START (蓝色)键	电源：	universal input 85-264 VAC, 50-60Hz,最大40 W
转棒停止：	RESET/STOP(红色)键	工作温度：	10°- 40°C
设置速度：	功能键	声级：	< 60 dB
速度重置：	RESET/STOP (红色)键	打印：	7145微型热敏打印机（需购置）
转子：	直径3cm转鼓

物理尺寸
净重：	11.0 Kg
尺寸：	46 (w) x 28 (d) x 33 (h) cm
毛重：	Kg 16.0 (approx.)
包装尺寸： 转子： 走道宽度： 下落高度：	66 x 50 x63 cm 直径3cm 5.7cm 16cm

特征	优点
转速可调5-80RPM，每次1RPM	予以小鼠舒适的活动环境
匀速，加速，多次加速模式（新）	可用于研究运动学习机运动功能
可使用USB闪存盘	无需连接电脑即可储存数据
新版软件	新款触摸屏能够设置实验参数、管理实验数据。

方法文献

§ N.W. Dunham & T.S. Miya: “A Note on a Sinple Apparatus for Detecting Neurological Deficit in Rats & Mice“ J. Am. Pharmaceut. Assoc., Scientific Edit., XLVI: No. 3, 1957

§ B.J. Jones & D.J. Roberts: “The Quantitative Measurement of Motor Inco-ordination in Naive Mice Using an Accelerating Rotarod“ J. Pharm. Pharmac.: 20: 302-304, 1968

使用转棒仪技术的相关文献：

§ B.J. Turner et alia: “Overexpression of Survival Motor Neuron Improves Neuromuscular Function and Motor Neuron Survival in Mutant SOD1 Mice” Neurobiol. Of Aging 35 (4): 906-915,2014

§ M. Milanese et alia: “Knocking Down Metabotropic Glutamate Receptor 1 Improves Survival And Disease Progression in the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis” Neurobiology of Disease 64: 48-59, 2014

§ J.E. Lorenz: “Oxidant-Induced Activation of cGMP-Dependent Protein Kinase Iα Mediates Neuropathic Pain After Peripheral Nerve Injury” Antioxidants & Redox Signaling Jan. 2014

§ J.N. Justice et alia: “Battery of Behavioral Tests in Mice that Models Age-Associated Changes in Human Motor Function” Age Oct 2013

§ A.S. Hamlin et alia: “Lesions of the Basal Forebrain Cholinergic System in Mice Disrupt Idiothetic Navigation” PLoS ONE 8(1): e53472, 2013

§ T. Rantamäki et alia: “The Impact of Bdnf Gene Deficiency to the Memory Impairment and Brain Pathology of APPswe/PS1dE9 Mouse Model of Alzheimer’s Disease” PLoS ONE 8(7): e68722, 2013

§ T. Murakami et alia: “Vascular Endothelial Growth Factor Electro-Gene Therapy Improves Functional Outcome in a Mouse Model of ALS” Immunology, Endocrine & Metabolic Agents: 13 (2): 107-111, 2013

§ R. Günther et alia: “Clinical Testing and Spinal Cord Removal in a Mouse Model for Amyotrophic Lateral Sclerosis (ALS)” JoVE J. Vis. Exp. (61), e3936, doi:10.3791/3936, 2012http://www.jove.com/video/3936/clinical-testing-spinal-cord-removal-mouse-model-for-amyotrophic

§ A.J. Grottick et alia: “Studies to investigate the role of 5-HT 2C Receptors on Cocaine- and Food-Maintained Behavior”: J. Pharmacol. Exper. Therap., 2000

§ L.T. Huang et alia: “Pentylenetetrazol-Induced Recurrent Seizures in Rat Pups: Time Course on Spatial Learning and Long…”: Epilepsia, 2002

§ E. Candelario-Jalil et alia: “Wide Therapeutic Time Window for Nimesulide Neuroprotection in a Model of Transient Focal Cerebral Ischemia in the Rat”: Brain Research: 177: 98-108, 2004

§ C.D. Heldermon et alia: “CliTherapeutic Efficacy of Bone Marrow Transplant, Intracranial AAV-mediated Gene Therapy, or Both in the Mouse Model of MPS IIIB” Molecular Therapy 15(5): 873-880, 2010  (rocking)